Who owns SAB BIOTHERAPEUTICS INC?
- Ticker: SABSW
- CUSIP Number: 78397t111
Tip: Access positions for across all investors
Analyze quarterly positions in Sab Biotherapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Sab Biotherapeutics stock
Who bought or sold SAB BIOTHERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| LMR Partners | 540k | $19k | 0% | Sep 2024 |
|
| HB Wealth Management | 310k | $11k | 100% | Sep 2024 |
|
| Morgan Stanley | 146k | $6.9k | -2% | Jun 2024 |
|
| Wolverine Asset Management | 16k | $558.684000 | 1% | Sep 2024 |
|
| Goss Wealth Management | 1.1k | $49.955200 | 0% | Jun 2024 |
|
| Tower Research Capital | 48.00 | $2.001600 | 0% | Jun 2024 |
|
Who sold out of Sab Biotherapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Shaolin Capital Management | Jun 2024 | 249k | $12k |
| Millennium Management | Jun 2024 | 63k | $3.0k |
| Bank of America Corporation | Jun 2024 | 200.00 | $9.000000 |
| Clear Street | Mar 2024 | 100.00 | $0 |